7 hours Kura Oncology Slams The Door On Its Takeover Narrative, And Shares Collapse 26%Investor's Business Daily
Kura Oncology slammed the door on its takeover narrative Thursday, inking a deal for its leukemia drug. Kura stock crashed.
The post Kura Oncology Slams The Door On Its Takeover Narrative, And Shares Collapse 26% appeared first on Investor's Busin…